NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient. Haematologica. 2018 Apr 27;: Authors: Sallman DA, Brayer J, Sagatys EM, Lonez C, Breman E, Agaugué S, Verma B, Gilham DE, Lehmann FF, Davila ML PMID: 29703727 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29703727?dopt=Abstract

Source: Haematologica - April 27, 2018 Category: Hematology Authors: Sallman DA, Brayer J, Sagatys EM, Lonez C, Breman E, Agaugué S, Verma B, Gilham DE, Lehmann FF, Davila ML Tags: Haematologica Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia